u/bastian_ekstrom

data logger is the standard, gut feeling is not

triple agonism plus glucagon is a different physiological state than GIP/GLP-1 dual

Not convinced. The evidence does not support that reading.

I am going to push back on this slightly.

Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.

the nausea from tirz is different, not necessarily worse

retatrutide is not approved anywhere for human use, posts must not read as instructions

stalled on sema, tried tirz, and the curves were actually different shapes

Yes, exactly this, and it is the bit that took me 74 weeks to accept.

Strongly agree. Central appetite is real but people overstate it.

network selection matters, wrong chain is the expensive typo

phase 2 is not phase 3, smaller n and shorter trial

retatrutide is not approved anywhere for human use, posts must not read as instructions

Half-life is about 168 hours, so steady state lands around week 22–5. Practical consequence: what you feel in week 1 is not what that dose does.

lane reports need origin, destination, carrier, and actual transit days

Did you stay on semaglutide or switch? The outcome is different if you are comparing.

This is the "correlation is mechanism" thing again. You changed three variables at once.

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

Disagree on that part. 93.7% and 99.3% on the same vial is normal.

no cold chain means ATTAIN, if approved

give the trial name, phase, n, and primary endpoint in the body

I am going to push back on this slightly.

Disagree on that part. 98.1% and 99.3% on the same vial is normal.